Skip to main content
. 2014 Dec 15;5(1):354–362.

Figure 2.

Figure 2

Influence of serum-tryptase levels on the survival in patients with CP-CML. Patients with normal serum-tryptase levels (≤15 ng/mL; solid line) and patients with elevated serum-tryptase levels (>15 ng/mL, dashed line) were compared. Significant differences in PFS were found (A; p<0.05). With regard to the EFS a markedly difference was found but the p value was 0.052 (B). Differences in OS rates were not statistically significant (C).